How common is PMS? The numbers

PMS is very common, but the exact share of people affected depends on the study, the country and how researchers measure it.

A systematic review and meta-analysis of nine studies in Ethiopia found a pooled PMS prevalence of 53% (PLOS ONE, 2020).

Those nine studies used different screening tools and were run in different regions, which is typical of how PMS research works worldwide. A few factors drive most of that range:

• How PMS is defined, as any noticeable change or only symptoms that disrupt daily life
• Which screening tool or questionnaire researchers use
• The country and population being studied

Other research puts the number far lower. Studies that require symptoms to interfere with work or relationships, rather than just noticing a change, tend to report smaller percentages.

There's no single agreed worldwide figure. A 2025 update to the Global Burden of Disease study, published in Reproductive Health, names PMS as one of the gynecological conditions behind a rising global burden of disease in women of childbearing age. That doesn't give an exact percentage, but it confirms how widespread the condition is.

Even that 53% figure means a substantial share of women in the same sample fell outside the threshold researchers used for PMS, a reminder that any single percentage is an average, not a diagnosis.

No. Plenty of people menstruate without any noticeable premenstrual symptoms.

Among those who do notice something, most have mild changes that don't disrupt their week. What is PMS? covers the full range, from mild bloating to mood changes that ease once bleeding starts. A smaller group has symptoms severe enough to affect work or relationships, and a smaller group still fits the pattern of PMDD, a separate diagnosis with its own criteria.

Researchers sometimes sort PMS into rough bands, no symptoms, mild symptoms that don't need treatment, and moderate to severe symptoms that affect daily function. People can move between these bands from one cycle to the next.

Having no premenstrual symptoms at all is normal. Severity also runs on a spectrum. The same person can have a mild month and a rough one back to back, and that alone doesn't signal anything is wrong.

A handful of larger reviews give the clearest picture, even though their methods differ. Browsing the wider PMS and PMDD research shows the same pattern. Numbers shift with definition and population.

Two of these four relied on systematic review methods, pooling multiple original studies rather than reporting a single survey. The Global Burden of Disease update used burden-of-disease modeling rather than a review of pooled studies, and the Fertility and Sterility narrative synthesis found a gap instead of a number, which is informative on its own.

That last row matters. There isn't yet a solid, race-disaggregated picture of PMS in the US, even though the condition has been studied worldwide.

Country and culture shape the reported numbers as much as biology does. The Ethiopian meta-analysis reports one of the higher figures in the published research (53%), while other national surveys land well below that, often because they count only symptoms that disrupt daily life.

Even within one country, urban and rural samples can report different rates. That gap often ties back to access to healthcare and how comfortable women feel describing symptoms to a researcher.

Age plays a role too, mostly through overlapping conditions. A large systematic review of 64,286 women found that being under 30, starting periods before age 12, and having heavier or longer cycles were all linked with painful periods, with PMS showing up repeatedly alongside those same risk factors (BMJ, 2006).

That pattern reflects overlapping risk factors, not proof that PMS itself gets worse with age. Painful periods and PMS often travel together in younger women, probably because both relate to how early periods started and how heavy the cycles are.

Many of the world's most populous countries don't yet have large, representative PMS prevalence studies. That gap is part of why global comparisons stay rough.

Three things drive most of the spread in reported numbers.

• Definition: some studies count anyone who notices any premenstrual change, others require symptoms that interfere with work, school or relationships.
• Method: a one-off question like 'do you get PMS' tends to produce different answers than symptom ratings kept daily across real cycles.
• Population: age range, country and who was recruited, university students versus a national sample, all shift the result.

These differences come from how researchers measure PMS, not from large shifts in the condition itself.

There's also a gap in who gets studied. A 2023 narrative synthesis in Fertility and Sterility searched for systematic reviews on racial or ethnic differences in PMS and PMDD in the US and found none that met its inclusion criteria. The numbers that do exist may not reflect every population equally.

Whatever the global percentage, your own pattern matters more day to day. If your symptoms show up in the week or two before your period and ease once it starts, that fits the usual PMS pattern, no matter which published number you'd land in. Most months will look a little different from each other, and that's part of a normal cycle.

The clearest way to find your pattern is to track it for yourself.

1. Write down your mood, energy and physical symptoms each day for two cycles.
2. Mark the day your period starts each time.
3. Look for symptoms that cluster in the days before bleeding and fade within a few days after it starts.

Niyora is a PMS and PMDD support app. Its estimated PMS window can show you, over a cycle or two, where your own pattern tends to sit, so you're working from your own data rather than someone else's statistic.